Busulfan analysis with quantitative UPLC-MS/MS for clinical research

Achieve rapid analysis and increased sensitivity

Traditional analytical methods encounter challenges when quantifying busulfan, an antineoplastic cancer therapy, due to its bioavailability. UPLC-MS/MS analysis with the ACQUITY UPLC I-Class PLUS and Xevo TQD Mass Spectrometer provides clinical research laboratories with highly selective and accurate data, as well as and rapid analysis and increased sensitivity.

가격 요청
  • 개요
  • 관련내용
  • 응용자료
`
맨 위로 돌아가기 맨 위로 돌아가기